1. Home
  2. BNED vs ALT Comparison

BNED vs ALT Comparison

Compare BNED & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNED
  • ALT
  • Stock Information
  • Founded
  • BNED 1965
  • ALT 1997
  • Country
  • BNED United States
  • ALT United States
  • Employees
  • BNED N/A
  • ALT N/A
  • Industry
  • BNED Other Specialty Stores
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNED Consumer Discretionary
  • ALT Health Care
  • Exchange
  • BNED Nasdaq
  • ALT Nasdaq
  • Market Cap
  • BNED 338.8M
  • ALT 333.6M
  • IPO Year
  • BNED N/A
  • ALT N/A
  • Fundamental
  • Price
  • BNED $9.66
  • ALT $3.91
  • Analyst Decision
  • BNED
  • ALT Strong Buy
  • Analyst Count
  • BNED 0
  • ALT 6
  • Target Price
  • BNED N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • BNED 302.1K
  • ALT 2.6M
  • Earning Date
  • BNED 09-12-2025
  • ALT 11-11-2025
  • Dividend Yield
  • BNED N/A
  • ALT N/A
  • EPS Growth
  • BNED N/A
  • ALT N/A
  • EPS
  • BNED N/A
  • ALT N/A
  • Revenue
  • BNED $1,567,800,000.00
  • ALT $20,000.00
  • Revenue This Year
  • BNED $2.74
  • ALT N/A
  • Revenue Next Year
  • BNED N/A
  • ALT N/A
  • P/E Ratio
  • BNED N/A
  • ALT N/A
  • Revenue Growth
  • BNED N/A
  • ALT N/A
  • 52 Week Low
  • BNED $7.90
  • ALT $2.90
  • 52 Week High
  • BNED $14.41
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • BNED 58.75
  • ALT 54.25
  • Support Level
  • BNED $9.48
  • ALT $3.68
  • Resistance Level
  • BNED $9.98
  • ALT $4.06
  • Average True Range (ATR)
  • BNED 0.34
  • ALT 0.23
  • MACD
  • BNED 0.06
  • ALT 0.02
  • Stochastic Oscillator
  • BNED 75.00
  • ALT 56.69

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: